
Super Collagen + Vitamin C & Biotin
NeoCell's Super Collagen + Vitamin C & Biotin is a combination supplement targeting skin, hair, and nail health, classified as an 'Other Combinations' type. Each serving provides 3 grams of Hydrolyzed Bovine Collagen, 30 mg of Vitamin C, and 2500 mcg of Biotin. Notably, the Biotin dosage is at a clinically studied level, which research suggests may support hair and nail strength. However, the Vitamin C dosage is underdosed compared to common recommendations for collagen synthesis support. The product holds an N+ Score of 74, earning a C+ grade, indicating a good quality product with 100% label transparency. Its ingredient adequacy is 50%, primarily due to the underdosed Vitamin C. This supplement may be suitable for individuals prioritizing Biotin and collagen intake for beauty support.
About This Product
Super Collagen + Vitamin C & Biotin by NeoCell is a collagen & beauty supplement containing 6 active ingredients. It has earned an N+ Score of 74/100 (Grade C+).
Notable clinical-dose ingredients include Biotin.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −No major weaknesses identified
Ingredient Analysis (6 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 10.000 Calorie(s) | N/A |
| Biotin | 2500.000 mcg | Optimal |
| Vitamin C | 30.000 mg | Under |
| Sodium | 15.000 mg | N/A |
| Protein | 3.000 Gram(s) | N/A |
| Bovine Collagen, Hydrolyzed | 3.000 Gram(s) | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.